Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EGF antibody

EGF Reactivity: Human ELISA (Capture) Host: Mouse Monoclonal S-134 unconjugated
Catalog No. ABIN114522
  • Target See all EGF Antibodies
    EGF (Epidermal Growth Factor (EGF))
    Reactivity
    • 144
    • 85
    • 50
    • 12
    • 11
    • 5
    • 4
    • 1
    • 1
    • 1
    Human
    Host
    • 210
    • 29
    • 9
    • 3
    • 1
    • 1
    Mouse
    Clonality
    • 215
    • 37
    Monoclonal
    Conjugate
    • 113
    • 36
    • 19
    • 14
    • 7
    • 7
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This EGF antibody is un-conjugated
    Application
    • 200
    • 87
    • 62
    • 53
    • 53
    • 29
    • 25
    • 24
    • 17
    • 16
    • 15
    • 14
    • 8
    • 8
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    ELISA (Capture)
    Specificity
    This antibody reacts with natural and recombinant human EGF. Does not cross react with other Human cytokines tested such as IL-1 beta, IL-8, MCAF, TGF-beta and SAA.
    Cross-Reactivity (Details)
    Species reactivity (tested):Human.
    Purification
    Affinity Chromatograpghy on Protein G.
    Immunogen
    Purified recombinant Human EGF, 6kDa, 53 amino acid residues
    Clone
    S-134
    Isotype
    IgG1
    Top Product
    Discover our top product EGF Primary Antibody
  • Application Notes
    ELISA: This antibody can be used as a Capture antibody in sandwich ELISA applications forHuman EGF detection in combination with a monoclonal tracer/detection antibody. Suggested Capture Coating Dose: 0.3 μg/well, Substrate: TMB. If the above suggestedconditions are followed approximately 20 pg/mL of EGF in serum/plasma or 15 pg/mL ofEGF in cell medium/urine can be detected with an assay range of 0-1000 pg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Reconstitution
    Restore with double distillated water is recommended to adjust the final concentration to 1.00 mg/mL
    Concentration
    1.00 mg/mL
    Buffer
    0.01 M PBS, pH 7.2 without preservatives
    Preservative
    Without preservative
    Handling Advice
    Avoid repeated freezing and thawing.
    Storage
    -20 °C
    Storage Comment
    Store the antibody at -20 °C. Can be shipped at 2 - 8 °C.
  • Target
    EGF (Epidermal Growth Factor (EGF))
    Alternative Name
    EGF (EGF Products)
    Synonyms
    HOMG4 antibody, URG antibody, AI790464 antibody, CEGF antibody, epidermal growth factor antibody, pro-epidermal growth factor antibody, EGF antibody, egf antibody, CpipJ_CPIJ020278 antibody, Egf antibody
    Background
    Epidermal growth factor (EGF) has a profound effect on the differentiation of specific cells in vivo and is a potent mitogenic factor for a variety of cultured cells. The EGF precursor is believed to exist as a membrane-bound molecule which is proteolytically cleaved to generate the 53-amino acid peptide hormone that stimulates cells to divide. EGF exerts its actions by binding to the EGFR, a 170 kDa protein. Epidermal growth factor (EGF) is a key growth factor regulating cell survival. Through its binding to cell surface receptors, EGF activates an extensive network of signal transduction pathways that include activation of the PI3K/AKT, RAS/ERK and JAK/STAT pathways. Because of its key role in driving the proliferation of cells, EGFR is a target of several anti-cancer drugs currently in development.Synonyms: Epidermal growth factor, HOMG4, Pro-epidermal growth factor, URG, Urogastrone
    Gene ID
    1950
    NCBI Accession
    NP_001954
    UniProt
    P01133
    Pathways
    NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
You are here:
Support